Abhinav A. Shukla, Chief Technical Officer at Shattuck Labs, Inc. (NASDAQ:STTK), sold 2,032 shares of common stock on May 12, 2026. The shares were sold at a weighted average price of $7.01, with individual transactions ranging from $7.00 to $7.02 per share. The total value amounted to $14,244.
The sale comes as the stock surged 574% over the past year, though it currently trades at $6.67—below Shukla’s sale price. The company has a market cap of $500 million.
The sale was executed under a Rule 10b5-1 trading plan adopted on February 2, 2026. This plan covers shares obtained from option exercises to cover exercise price and tax withholding.
Prior to the sale, Shukla acquired 2,032 shares through stock option exercises at $3.57 per share, totaling $7,254. After the transactions, he directly holds 81,258 shares and 50,168 unexercised options.
In other news, TD Cowen reiterated a Buy rating on Shattuck Labs following positive toxicology studies for its drug candidate SL-325, which showed a favorable safety profile.
